Example of Veterinary and Comparative Oncology format
Recent searches

Example of Veterinary and Comparative Oncology format Example of Veterinary and Comparative Oncology format Example of Veterinary and Comparative Oncology format Example of Veterinary and Comparative Oncology format Example of Veterinary and Comparative Oncology format Example of Veterinary and Comparative Oncology format
Sample paper formatted on SciSpace - SciSpace
This content is only for preview purposes. The original open access content can be found here.
Look Inside
Example of Veterinary and Comparative Oncology format Example of Veterinary and Comparative Oncology format Example of Veterinary and Comparative Oncology format Example of Veterinary and Comparative Oncology format Example of Veterinary and Comparative Oncology format Example of Veterinary and Comparative Oncology format
Sample paper formatted on SciSpace - SciSpace
This content is only for preview purposes. The original open access content can be found here.
open access Open Access
recommended Recommended

Veterinary and Comparative Oncology — Template for authors

Publisher: Wiley
Categories Rank Trend in last 3 yrs
Veterinary (all) #12 of 183 up up by 7 ranks
journal-quality-icon Journal quality:
High
calendar-icon Last 4 years overview: 401 Published Papers | 1723 Citations
indexed-in-icon Indexed in: Scopus
last-updated-icon Last updated: 06/07/2020
Related journals
Insights
General info
Top papers
Popular templates
Get started guide
Why choose from SciSpace
FAQ

Related Journals

open access Open Access

SAGE

Quality:  
High
CiteRatio: 3.1
SJR: 0.62
SNIP: 0.797
open access Open Access
recommended Recommended

SAGE

Quality:  
High
CiteRatio: 3.9
SJR: 0.794
SNIP: 1.405
open access Open Access

SAGE

Quality:  
High
CiteRatio: 2.2
SJR: 0.529
SNIP: 0.848
open access Open Access

Frontiers Media

Quality:  
High
CiteRatio: 2.6
SJR: 0.877
SNIP: 1.347

Journal Performance & Insights

Impact Factor

CiteRatio

Determines the importance of a journal by taking a measure of frequency with which the average article in a journal has been cited in a particular year.

A measure of average citations received per peer-reviewed paper published in the journal.

1.749

26% from 2018

Impact factor for Veterinary and Comparative Oncology from 2016 - 2019
Year Value
2019 1.749
2018 2.379
2017 2.27
2016 1.819
graph view Graph view
table view Table view

4.3

CiteRatio for Veterinary and Comparative Oncology from 2016 - 2020
Year Value
2020 4.3
2019 4.3
2018 3.9
2017 3.0
2016 3.6
graph view Graph view
table view Table view

insights Insights

  • Impact factor of this journal has decreased by 26% in last year.
  • This journal’s impact factor is in the top 10 percentile category.

insights Insights

  • This journal’s CiteRatio is in the top 10 percentile category.

SCImago Journal Rank (SJR)

Source Normalized Impact per Paper (SNIP)

Measures weighted citations received by the journal. Citation weighting depends on the categories and prestige of the citing journal.

Measures actual citations received relative to citations expected for the journal's category.

0.864

4% from 2019

SJR for Veterinary and Comparative Oncology from 2016 - 2020
Year Value
2020 0.864
2019 0.903
2018 1.507
2017 0.946
2016 0.87
graph view Graph view
table view Table view

1.164

1% from 2019

SNIP for Veterinary and Comparative Oncology from 2016 - 2020
Year Value
2020 1.164
2019 1.179
2018 1.512
2017 1.779
2016 0.979
graph view Graph view
table view Table view

insights Insights

  • SJR of this journal has decreased by 4% in last years.
  • This journal’s SJR is in the top 10 percentile category.

insights Insights

  • SNIP of this journal has decreased by 1% in last years.
  • This journal’s SNIP is in the top 10 percentile category.

Veterinary and Comparative Oncology

Guideline source: View

All company, product and service names used in this website are for identification purposes only. All product names, trademarks and registered trademarks are property of their respective owners.

Use of these names, trademarks and brands does not imply endorsement or affiliation. Disclaimer Notice

Wiley

Veterinary and Comparative Oncology

Veterinary and Comparative Oncology is an international, peer-reviewed journal integrating clinical and scientific information for all veterinarians and scientists concerned with aetiology, diagnosis and clinical course of cancer in domestic animals and its prevention. The Jou...... Read More

Veterinary

i
Last updated on
05 Jul 2020
i
ISSN
1476-5829
i
Impact Factor
High - 1.083
i
Open Access
Yes
i
Sherpa RoMEO Archiving Policy
Yellow faq
i
Plagiarism Check
Available via Turnitin
i
Endnote Style
Download Available
i
Bibliography Name
apa
i
Citation Type
Numbered
[25]
i
Bibliography Example
Blonder G. E., Tinkham M., Klapwijk T. M.. Transition from metallic to tunneling regimes in superconducting microconstrictions: Excess current, charge imbalance, and supercurrent conversion Phys. Rev. B. 1982;25:4515-4532.

Top papers written in this journal

Journal Article DOI: 10.1111/J.1476-5829.2007.00142.X
Cisplatin: a review of toxicities and therapeutic applications.
Karri Barabas1, Rowan J. Milner1, David M. Lurie1, Christopher A. Adin1

Abstract:

Cisplatin is a platinum chemotherapeutic used in a variety of malignancies. The antineoplastic activity occurs from DNA cross-links and adducts, in addition to the generation of superoxide radicals. Nephrotoxicity is the most well-known and potentially most clinically significant toxicity. Unfortunately, the mechanism for cis... Cisplatin is a platinum chemotherapeutic used in a variety of malignancies. The antineoplastic activity occurs from DNA cross-links and adducts, in addition to the generation of superoxide radicals. Nephrotoxicity is the most well-known and potentially most clinically significant toxicity. Unfortunately, the mechanism for cisplatin nephrotoxicity has not been completely elucidated; however, many theories have been developed. Other toxicities include gastrointestinal, myelosuppression, ototoxicity and neurotoxicity. Saline diuresis is currently the most accepted way to prevent cisplatin nephrotoxicity. Research has focused on pharmaceuticals and enzyme/molecular alterations as alternatives to long-term diuresis. No agents have currently been identified that can protect from all toxicities. Cisplatin has shown activity against osteosarcoma, transitional cell carcinoma, squamous cell carcinoma (SCC), melanoma, mesothelioma, carcinomatosis and germinal cell tumours in the dog. In the cat, cisplatin cannot be utilized because of fulminant pulmonary oedema that occurs at standard doses. Intralesional cisplatin has been utilized in horses for the treatment of SCC and sarcoids. read more read less

Topics:

Cisplatin (54%)54% related to the paper, Nephrotoxicity (52%)52% related to the paper, Ototoxicity (52%)52% related to the paper
340 Citations
Journal Article DOI: 10.1111/VCO.12032
Response evaluation criteria for solid tumours in dogs (v1.0): a Veterinary Cooperative Oncology Group (VCOG) consensus document
Sandra M. Nguyen1, Douglas H. Thamm2, David M. Vail3, Cheryl A. London1

Abstract:

In veterinary medical oncology, there is currently no standardized protocol for assessing response to therapy in solid tumours. The lack of such a formalized guideline makes it challenging to critically compare outcome measures across various treatment protocols. The Veterinary Cooperative Oncology Group (VCOG) membership con... In veterinary medical oncology, there is currently no standardized protocol for assessing response to therapy in solid tumours. The lack of such a formalized guideline makes it challenging to critically compare outcome measures across various treatment protocols. The Veterinary Cooperative Oncology Group (VCOG) membership consensus document presented here is based on the recommendations of a subcommittee of American College of Veterinary Internal Medicine (ACVIM) board-certified veterinary oncologists. This consensus paper has used the human response evaluation criteria in solid tumours (RECIST v1.1) as a framework to establish standard procedures for response assessment in canine solid tumours that is meant to be easy to use, repeatable and applicable across a variety of clinical trial structures in veterinary oncology. It is hoped that this new canine RECIST (cRECIST v1.0) will be adopted within the veterinary oncology community and thereby facilitate the comparison of current and future treatment protocols used for companion animals with cancer. read more read less

Topics:

Veterinary oncology (64%)64% related to the paper
276 Citations
Journal Article DOI: 10.1111/J.1476-5829.2009.00200.X
Response evaluation criteria for peripheral nodal lymphoma in dogs (v1.0)--a Veterinary Cooperative Oncology Group (VCOG) consensus document.
David M. Vail1, G. M. Michels2, Chand Khanna3, Kim A. Selting4, Cheryl A. London5

Abstract:

Standardized assessment of response to therapy for lymphoma in dogs is lacking, making critical comparisons of treatment protocols difficult. This Veterinary Cooperative Oncology Group (VCOG) consensus document, based on the recommendations of a subcommittee of ACVIM board-certified veterinary oncologists, was unanimously ado... Standardized assessment of response to therapy for lymphoma in dogs is lacking, making critical comparisons of treatment protocols difficult. This Veterinary Cooperative Oncology Group (VCOG) consensus document, based on the recommendations of a subcommittee of ACVIM board-certified veterinary oncologists, was unanimously adopted at the 29th Annual Conference of the Veterinary Cancer Society (VCS) by the VCOG membership. It has integrated guidance from the response assessment criteria established for lymphoma in human patients using standards available in routine veterinary oncology practices that are simple, repeatable and consistently applicable. These guidelines are intended only for use in dogs, where peripheral lymphadenopathy represents the principal component of their disease and as such do not critically assess extranodal disease (e.g., primary cutaneous, central nervous system, gastrointestinal). It is hoped these guidelines will be widely adopted and serve to facilitate the comparison of current and future treatment protocols used in the therapy of dogs. read more read less

Topics:

Veterinary oncology (62%)62% related to the paper
View PDF
210 Citations
open accessOpen access Journal Article DOI: 10.1111/J.1476-5829.2012.00341.X
European consensus document on mast cell tumours in dogs and cats.

Abstract:

In preparing this document the Authors aimed to pool current information on canine and feline mast cell disease. The information was gathered from international studies and a emphasis was placed on material and opinion with a strong evidence base. We intend it to form the basis of our understanding in this disease at the curr... In preparing this document the Authors aimed to pool current information on canine and feline mast cell disease. The information was gathered from international studies and a emphasis was placed on material and opinion with a strong evidence base. We intend it to form the basis of our understanding in this disease at the current time and we anticipate that it will be particularly useful for the general practitioner. It should be emphasized that the authors are presenting this work from a European perspective. read more read less
View PDF
182 Citations
open accessOpen access Journal Article DOI: 10.1111/J.1476-5829.2011.00275.X
Preliminary evidence for biologic activity of toceranib phosphate (Palladia®) in solid tumours

Abstract:

The purpose of this study was to provide an initial assessment of the potential biologic activity of toceranib phosphate (Palladia®, Pfizer Animal Health, Madison, NJ, USA) in select solid tumours in dogs. Cases in which toceranib was used to treat dogs with apocrine gland anal sac adenocarcinoma (AGASACA), metastatic osteosa... The purpose of this study was to provide an initial assessment of the potential biologic activity of toceranib phosphate (Palladia®, Pfizer Animal Health, Madison, NJ, USA) in select solid tumours in dogs. Cases in which toceranib was used to treat dogs with apocrine gland anal sac adenocarcinoma (AGASACA), metastatic osteosarcoma (OSA), thyroid carcinoma, head and neck carcinoma and nasal carcinoma were included. Clinical benefit (CB) was observed in 63/85 (74%) dogs including 28/32 AGASACA [8 partial response (PR), 20 stable disease (SD)], 11/23 OSAs (1 PR and 10 SD), 12/15 thyroid carcinomas (4 PR and 8 SD), 7/8 head and neck carcinomas [1 complete response (CR), 5 PR and 1 SD] and 5/7 (1 CR and 4 SD) nasal carcinomas. For dogs experiencing CB, the median dose of toceranib was 2.8 mg kg(-1) , 36/63 (58.7%) were dosed on a Monday/Wednesday/Friday basis and 47/63 (74.6%) were treated 4 months or longer. Although these data provide preliminary evidence that toceranib exhibits CB in dogs with certain solid tumours, future prospective studies are necessary to define its true activity. read more read less

Topics:

Toceranib (70%)70% related to the paper, Anal sac adenocarcinoma (51%)51% related to the paper
View PDF
172 Citations
Author Pic

SciSpace is a very innovative solution to the formatting problem and existing providers, such as Mendeley or Word did not really evolve in recent years.

- Andreas Frutiger, Researcher, ETH Zurich, Institute for Biomedical Engineering

Get MS-Word and LaTeX output to any Journal within seconds
1
Choose a template
Select a template from a library of 40,000+ templates
2
Import a MS-Word file or start fresh
It takes only few seconds to import
3
View and edit your final output
SciSpace will automatically format your output to meet journal guidelines
4
Submit directly or Download
Submit to journal directly or Download in PDF, MS Word or LaTeX

(Before submission check for plagiarism via Turnitin)

clock Less than 3 minutes

What to expect from SciSpace?

Speed and accuracy over MS Word

''

With SciSpace, you do not need a word template for Veterinary and Comparative Oncology.

It automatically formats your research paper to Wiley formatting guidelines and citation style.

You can download a submission ready research paper in pdf, LaTeX and docx formats.

Time comparison

Time taken to format a paper and Compliance with guidelines

Plagiarism Reports via Turnitin

SciSpace has partnered with Turnitin, the leading provider of Plagiarism Check software.

Using this service, researchers can compare submissions against more than 170 million scholarly articles, a database of 70+ billion current and archived web pages. How Turnitin Integration works?

Turnitin Stats
Publisher Logos

Freedom from formatting guidelines

One editor, 100K journal formats – world's largest collection of journal templates

With such a huge verified library, what you need is already there.

publisher-logos

Easy support from all your favorite tools

Veterinary and Comparative Oncology format uses apa citation style.

Automatically format and order your citations and bibliography in a click.

SciSpace allows imports from all reference managers like Mendeley, Zotero, Endnote, Google Scholar etc.

Frequently asked questions

1. Can I write Veterinary and Comparative Oncology in LaTeX?

Absolutely not! Our tool has been designed to help you focus on writing. You can write your entire paper as per the Veterinary and Comparative Oncology guidelines and auto format it.

2. Do you follow the Veterinary and Comparative Oncology guidelines?

Yes, the template is compliant with the Veterinary and Comparative Oncology guidelines. Our experts at SciSpace ensure that. If there are any changes to the journal's guidelines, we'll change our algorithm accordingly.

3. Can I cite my article in multiple styles in Veterinary and Comparative Oncology?

Of course! We support all the top citation styles, such as APA style, MLA style, Vancouver style, Harvard style, and Chicago style. For example, when you write your paper and hit autoformat, our system will automatically update your article as per the Veterinary and Comparative Oncology citation style.

4. Can I use the Veterinary and Comparative Oncology templates for free?

Sign up for our free trial, and you'll be able to use all our features for seven days. You'll see how helpful they are and how inexpensive they are compared to other options, Especially for Veterinary and Comparative Oncology.

5. Can I use a manuscript in Veterinary and Comparative Oncology that I have written in MS Word?

Yes. You can choose the right template, copy-paste the contents from the word document, and click on auto-format. Once you're done, you'll have a publish-ready paper Veterinary and Comparative Oncology that you can download at the end.

6. How long does it usually take you to format my papers in Veterinary and Comparative Oncology?

It only takes a matter of seconds to edit your manuscript. Besides that, our intuitive editor saves you from writing and formatting it in Veterinary and Comparative Oncology.

7. Where can I find the template for the Veterinary and Comparative Oncology?

It is possible to find the Word template for any journal on Google. However, why use a template when you can write your entire manuscript on SciSpace , auto format it as per Veterinary and Comparative Oncology's guidelines and download the same in Word, PDF and LaTeX formats? Give us a try!.

8. Can I reformat my paper to fit the Veterinary and Comparative Oncology's guidelines?

Of course! You can do this using our intuitive editor. It's very easy. If you need help, our support team is always ready to assist you.

9. Veterinary and Comparative Oncology an online tool or is there a desktop version?

SciSpace's Veterinary and Comparative Oncology is currently available as an online tool. We're developing a desktop version, too. You can request (or upvote) any features that you think would be helpful for you and other researchers in the "feature request" section of your account once you've signed up with us.

10. I cannot find my template in your gallery. Can you create it for me like Veterinary and Comparative Oncology?

Sure. You can request any template and we'll have it setup within a few days. You can find the request box in Journal Gallery on the right side bar under the heading, "Couldn't find the format you were looking for like Veterinary and Comparative Oncology?”

11. What is the output that I would get after using Veterinary and Comparative Oncology?

After writing your paper autoformatting in Veterinary and Comparative Oncology, you can download it in multiple formats, viz., PDF, Docx, and LaTeX.

12. Is Veterinary and Comparative Oncology's impact factor high enough that I should try publishing my article there?

To be honest, the answer is no. The impact factor is one of the many elements that determine the quality of a journal. Few of these factors include review board, rejection rates, frequency of inclusion in indexes, and Eigenfactor. You need to assess all these factors before you make your final call.

13. What is Sherpa RoMEO Archiving Policy for Veterinary and Comparative Oncology?

SHERPA/RoMEO Database

We extracted this data from Sherpa Romeo to help researchers understand the access level of this journal in accordance with the Sherpa Romeo Archiving Policy for Veterinary and Comparative Oncology. The table below indicates the level of access a journal has as per Sherpa Romeo's archiving policy.

RoMEO Colour Archiving policy
Green Can archive pre-print and post-print or publisher's version/PDF
Blue Can archive post-print (ie final draft post-refereeing) or publisher's version/PDF
Yellow Can archive pre-print (ie pre-refereeing)
White Archiving not formally supported
FYI:
  1. Pre-prints as being the version of the paper before peer review and
  2. Post-prints as being the version of the paper after peer-review, with revisions having been made.

14. What are the most common citation types In Veterinary and Comparative Oncology?

The 5 most common citation types in order of usage for Veterinary and Comparative Oncology are:.

S. No. Citation Style Type
1. Author Year
2. Numbered
3. Numbered (Superscripted)
4. Author Year (Cited Pages)
5. Footnote

15. How do I submit my article to the Veterinary and Comparative Oncology?

It is possible to find the Word template for any journal on Google. However, why use a template when you can write your entire manuscript on SciSpace , auto format it as per Veterinary and Comparative Oncology's guidelines and download the same in Word, PDF and LaTeX formats? Give us a try!.

16. Can I download Veterinary and Comparative Oncology in Endnote format?

Yes, SciSpace provides this functionality. After signing up, you would need to import your existing references from Word or Bib file to SciSpace. Then SciSpace would allow you to download your references in Veterinary and Comparative Oncology Endnote style according to Elsevier guidelines.

Fast and reliable,
built for complaince.

Instant formatting to 100% publisher guidelines on - SciSpace.

Available only on desktops 🖥

No word template required

Typset automatically formats your research paper to Veterinary and Comparative Oncology formatting guidelines and citation style.

Verifed journal formats

One editor, 100K journal formats.
With the largest collection of verified journal formats, what you need is already there.

Trusted by academicians

I spent hours with MS word for reformatting. It was frustrating - plain and simple. With SciSpace, I can draft my manuscripts and once it is finished I can just submit. In case, I have to submit to another journal it is really just a button click instead of an afternoon of reformatting.

Andreas Frutiger
Researcher & Ex MS Word user
Use this template